Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals has entered into distributorship arrangements with 28 leading surgical and medical instrument manufacturers for distribution of their products across India. The portfolio covers a wide range of categories including hematology analyzers, vision and eye care equipment, orthopedic implants, ICU and NICU equipment, wound management products, infusion systems, laparoscopic equipment, and lab diagnostic instruments. Notable partners include Trivitron Healthcare, Nidek, B. Braun, Molnlycke Healthcare, Convatec, and DJO Global. The company states these alliances are aimed at diversifying into the growing medical devices and surgical instruments market and are expected to contribute significantly to revenue and business growth. No specific revenue figures, contract values, or timelines have been disclosed.
Positive narrative for business expansion and revenue diversification, but lacks concrete financial details such as expected revenue contribution or contract values, limiting its immediate impact on stock price assessment.